| 1 |
35363774 | The role of CDH2 and MCP-1 mRNAs of blood extracellular vesicles in predicting early-stage diabetic nephropathy. | 2022 |
1 |
| 2 |
35464092 | Expression of CCL2, FOS, and JUN May Help to Distinguish Patients With IgA Nephropathy From Healthy Controls. | 2022 |
1 |
| 3 |
31442679 | Evidence for interactions between inflammatory markers and renin-angiotensin system molecules in the occurrence of albuminuria in children with sickle cell anemia. | 2020 Jan |
2 |
| 4 |
32818222 | Urine hepcidin, netrin-1, neutrophil gelatinase-associated lipocalin and C-C motif chemokine ligand 2 levels in multicystic dysplastic kidney. | 2020 Jul-Sep |
2 |
| 5 |
33401355 | Potential Role of Monocyte Chemoattractant Protein-1 in Monitoring Disease Progression and Response to Treatment in Overactive Bladder Patients. | 2020 Dec |
3 |
| 6 |
31023272 | Effects of Brazilian green propolis on proteinuria and renal function in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled trial. | 2019 Apr 25 |
1 |
| 7 |
31250339 | Association of urinary monocyte chemoattractant protein-1 (MCP-1) and kidney injury molecule-1 (KIM-1) with risk factors of diabetic kidney disease in type 2 diabetes patients. | 2019 Aug |
2 |
| 8 |
31258944 | Characterisation of urinary monocyte chemoattractant protein 1: Potential biomarker for patients with overactive bladder. | 2019 Mar |
1 |
| 9 |
30230985 | Increased Serum MCP-1 Levels in Systemic Vasculitis Patients with Renal Involvement. | 2018 Sep |
1 |
| 10 |
26609908 | Influence and analysis of low-dosage steroid therapy in severe aristolochic acid nephropathy patients. | 2016 Oct |
1 |
| 11 |
27189318 | Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial. | 2016 Aug 8 |
4 |
| 12 |
27296256 | [Acute kidney injury and tubular biomarkers after hematopoietic stem cell transplantation]. | 2016 |
1 |
| 13 |
27548845 | Six-Month Urinary CCL2 and CXCL10 Levels Predict Long-term Renal Allograft Outcome. | 2016 Sep |
1 |
| 14 |
26022021 | Urinary monocyte chemoattractant protein-1 as a biomarker of lupus nephritis activity in children. | 2015 May-Jun |
2 |
| 15 |
26335292 | MCP1 2518 A/G polymorphism affects progression of childhood focal segmental glomerulosclerosis. | 2015 |
1 |
| 16 |
24414608 | Urinary MCP-1/creatinine in Henoch-Schönlein purpura and its relationship with nephritis. | 2014 Jun |
1 |
| 17 |
23515495 | Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy. | 2013 Oct |
1 |
| 18 |
23611517 | Up-regulation of urinary markers predict outcome in IgA nephropathy but their predictive value is influenced by treatment with steroids and azathioprine. | 2013 Sep |
1 |
| 19 |
22609259 | The levels of circulating and urinary monocyte chemoattractant protein-1 are associated with chronic renal injury in obese men. | 2012 Oct 9 |
1 |
| 20 |
20437404 | Urinary monocyte chemotactic protein 1: marker of renal function decline in diabetic and nondiabetic proteinuric renal disease. | 2011 Jan-Feb |
2 |
| 21 |
21042828 | Renoprotective effects of clarithromycin via reduction of urinary MCP-1 levels in type 2 diabetic patients. | 2011 Feb |
1 |
| 22 |
19409809 | Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy. | 2009 Jul |
1 |
| 23 |
20374368 | Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis. | 2009 Dec |
1 |
| 24 |
17943082 | The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. | 2008 Feb |
1 |
| 25 |
18047927 | Activated cells in urine and monocyte chemotactic peptide-1 (MCP-1)--sensitive rejection markers in renal graft recipients. | 2008 Jan |
1 |
| 26 |
18235151 | Reduced albuminuria with sarpogrelate is accompanied by a decrease in monocyte chemoattractant protein-1 levels in type 2 diabetes. | 2008 Mar |
1 |
| 27 |
18528327 | The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease. | 2008 Aug |
2 |
| 28 |
18974575 | Correlation of urinary monocyte chemo-attractant protein-1 with other parameters of renal injury in type-II diabetes mellitus. | 2008 Nov |
2 |
| 29 |
16541021 | Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases. | 2006 Apr |
3 |
| 30 |
16966829 | Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy. | 2006 Dec |
1 |
| 31 |
16334978 | Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis. | 2005 |
1 |
| 32 |
12505750 | Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. | 2003 Jan-Feb |
2 |
| 33 |
12803507 | Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases. | 2003 May |
1 |
| 34 |
12882873 | ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1. | 2003 Aug |
2 |
| 35 |
14514736 | Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease. | 2003 Oct |
2 |
| 36 |
10446112 | Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease. | 1999 Sep |
1 |
| 37 |
10572396 | [The role of monocyte chemotactic and activating factor (MCAF)/monocyte chemoattractant protein (MCP)-1 in subgroups of rapidly progressive glomerulonephritis]. | 1999 Oct |
2 |
| 38 |
9760814 | [The role of monocyte chemotactic peptide (MCP-1) in chronic renal allograft rejection]. | 1998 Apr |
4 |
| 39 |
8671975 | Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection. | 1996 Jun |
1 |